Pfizer

Traded on the St. Petersburg Stock Exchange
Pfizer is an American multinational pharmaceutical corporation headquartered in New York City. It is one of the world's largest pharmaceutical companies. The company develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, endocrinology, and neurology. Its products include the blockbuster drug Lipitor, used to lower LDL blood cholesterol. The most famous brands are: "Lyrica", "Diflucan", " Zithromax", "Viagra", "Celebrex".
Pfizer stock price chart
+1%
P/E adj.
Net profit (adj.)
P/B
Book value
Debts
Net debt
Yield
Growth potential

Pfizer balance sheet

Report period2017 2018 2019 2020 2021 Q2 22
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Pfizer cash flows

Report period2017 2018 2019 2020 2021 Q2 22 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Pfizer multipliers

Report period2017 2018 2019 2020 2021 Q2 22 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Pfizer profitability

Report period2017 2018 2019 2020 2021 Q2 22 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Pfizer assets
Pfizer cash flows
Pfizer dividends
3.16%

Pfizer shares

TickerNameTypeNominal valueISINPrice
PFE:USPfizer Inc.Common share-US7170811035$43.76

Pfizer expected events

DateTypeNoteSource
02.11.2022 10:00
Dividends
The last day of purchase for receiving dividends $0.4 per common share for Q4 Fiscal Year 2022.Pictogram of investors.pfizer.com  investors.pfizer.com
05.12.2022 10:00
Dividends
The company will pay dividends of $0.4 per common share for Q4 Fiscal Year 2022.Pictogram of investors.pfizer.com  investors.pfizer.com
Pfizer news
22.09.2022
The Pfizer Board of Directors announced a quarterly dividend of $0.4 per share. The last day to buy securities to receive the dividend is November 2, 2022. The annual dividend yield may reach 3.16%.
16.09.2022
EMA has recommended a permanent marketing authorization in the EU for Pfizer-BioNTech's COVID-19 vaccine. A conditional marketing authorization is currently in effect and must be renewed annually.
26.08.2022
Moderna has sued Pfizer and BioNTech in the U.S. District Court in Massachusetts and in a regional court in Düsseldorf, Germany. Company believes that Pfizer and BioNTech copied Moderna's patented 2010-2016 foundational mRNA technology to develop their COVID-19 Comirnaty vaccine. Moderna demands that Pfizer and BioNTech pay compensation for the use of its pa...
17.08.2022
The U.S. Government has ordered 105 million doses of Pfizer-BioNTech vaccine from COVID-19 for $3.2 billion. Agreement also includes an option for another 195 million doses. Deliveries will begin in late summer and continue in fourth quarter of this year.
General information
Company namePfizer
Tags#pharmacy, #s&p500 index, #coronavirus, #vaccines
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address235 E 42ND ST NEW YORK NY 10017 2125732323
Mailing address235 E 42ND ST NEW YORK NY 10017
Websiteinvestors.pfizer.com
Information disclosurewww.sec.gov